Background
Gray font color on white background Black font color on white background White font color on black background White font color on dark blue background
Font Size
Search Message Boards » Macular Degeneration

<< Back to Forums

Please login to post a response.

  • Anti fungal drugs and myopic md/and/or ARMD
  • Posted: 2008-03-24 12:49:28 By Mary S
  • hello folks. well it looks as though there is an antifungal agent out there that when taken PO is helping some one I know, to keep her wet and hard to treat myopic eye dry.

    she has been trying to get a RS/researcher to look at this,As she has been taking it for its original purpose, and this was a side benefit.

    She has had Intravenous avastin, and intravitreal avastin and Lucentis, none of which kept her dry for very long. this seems to be doing the trick and has had the most benefit.

    I do know they are planning , if they have not started useing it, for cancer patients.
    the drug is called.
    Itraconazole

  • Re: Anti fungal drugs and myopic md/and/or ARMD
  • Posted: 2008-03-24 12:58:13 By Mary S

  • Public release date: 27-Apr-2007

    Contact: Nick Zagorski
    nzagors1@jhmi.edu
    443-287-2251
    Johns Hopkins Medical Institutions

    Anti-fungal drug stops blood vessel growth
    Researchers at Johns Hopkins have discovered to their surprise that a drug commonly used to treat toenail fungus can also block angiogenesis, the growth of new blood vessels commonly seen in cancers. The drug, itraconazole, already is FDA approved for human use, which may fast-track its availability as an antiangiogenesis drug.

    In mice induced to have excess blood vessel growth, treatment with itraconazole reduced blood vessel growth by 67 percent compared to placebo. “We were surprised, to say the least, that itraconazole popped up as a potential blocker of angiogenesis,” says Jun O. Liu, Ph.D., professor of pharmacology. “We couldn’t have predicted that an antifungal drug would have such a role.”

    In their search for antiangiogenesis drugs, the researchers worked with cells from human umbilical cords, a rich source of blood vessels, and exposed them to 2,400 existing drugs - including FDA- and foreign-approved drugs, as well as nonapproved drugs that had passed safety trials - to see which ones could stop the cells from dividing.

    “The best outcome was to find an already approved drug that worked, and the fact that we did was very satisfying,” says Liu, whose study appears online in ACS Chemical Biology.

    As an antifungal drug, itraconazole blocks a key enzyme for making fungal cholesterol, causing these primitive life forms to become fragile and break apart. It turns out that itraconazole can block the same enzyme in blood vessels, but the researchers aren’t positive if that’s the reason blood vessels stop growing, because related antifungal drugs had much lower inhibitory effect.

    “Our screening test did show that cholesterol-lowering statins also appear to stop blood vessel growth,” Liu says, “so there is likely some important connection between cholesterol and angiogenesis.”

    While the researchers still must tease out exactly how itraconazole works to stop vessel growth, and test it in animals with cancer, they have high hopes for its use. “Itraconazole can be taken orally for fungal infection, and therefore oral delivery may work for angiogenesis as well,” Liu notes.


    ###
    The research was funded by the Johns Hopkins School of Medicine, the Johns Hopkins Fund for Medical Discovery, the Johns Hopkins Malaria Research Institute, the Keck Foundation, and the Flight Attendant Medical Research Institute Fund.

    Authors on the paper are Curtis Chong, Jing Xu, Jun Lu, Shridhar Bhat, David Sullivan Jr. and Jun O. Liu, all of Johns Hopkins.

    On the Web:
    http://www.hopkinsmedicine.org/pharmacology/index.html
    http://pubs.acs.org/journals/acbcct/index.html

    Johns Hopkins Medicine
    Media Relations and Public Affairs
    Media Contacts: Nick Zagorski; 443-287-2251; nzagors1@jhmi.edu
    Audrey Huang; 410-614-5105; audrey@jhmi.edu


    http://www.eurekalert.org/pub_releases/2007-04/jhmi-ads042707.php

  • Re: Anti fungal drugs and myopic md/and/or ARMD
  • Posted: 2008-04-03 16:49:18 By Debra U
  • There is probably no connection, but I have dry
    AMD. I also (think I) have a fungal infection in my scalp which I have been treating with Nioxin
    hair products. Since this drug you mentoned is antifungal that you mentioned,
    although I know it inhibits vessel growth, I wonder if AMD is somehow of fungal origin.





  • Re: Anti fungal drugs and myopic md/and/or ARMD
  • Posted: 2008-04-03 16:50:48 By Debra U
  • Where does your friend go to the doctor?
  • Re: Re: Anti fungal drugs and myopic md/and/or ARMD
  • Posted: 2008-04-03 20:00:49 By Mary S
  • My frined lives in Arizona, I am not sure how to answer that question about were she goes to the doctor.
    the antifungal drug she was taking was oraly. not topically.
    mar
US Images

Chapters

Select a state from the dropdown below to view local chapters.


Free Information

Register here to receive free information about your eye condition and research efforts to find treatments and cures.

2012 Annual Report banner
VISIONS 2013 - Side Box banner
VisionWalk banner
Events Calendar